Relmada Therapeutics, Inc. [RLMD]

Source: 

Company Overview

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development of esmethadone, an N-methyl-D-aspartate receptor antagonist. Esmethadone, an isomer of methadone, is a new chemical entity thatpotentially addresses areas of high unmet medical need in the treatment of central nervous system diseases and other disorders.